Medeon Biodesign

Medeon Biodesign EBIT per Share

The EBIT per Share of Medeon Biodesign (6499.TWO) as of Nov 6, 2026 is -7.45 TWD. In the previous year, EBIT per Share was -9.47 TWD — a change of -21.27% (higher).

EBIT per Share

-7.45TWD

YoY

-21.27%

Last updated:

EBIT per Share of Medeon Biodesign is 2025 -7.45 TWD. EBIT per Share of Medeon Biodesign was 2024 -9.47 TWD. It decreases by -21.27% higher compared to the previous year.

The Medeon Biodesign EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-1.33 TWD
Jan 1, 2021
-6.80 TWD
Jan 1, 2022
-5.57 TWD
Jan 1, 2023
-9.14 TWD
Jan 1, 2024
-9.47 TWD
Jan 1, 2025
-7.45 TWD
Jan 1, 2026 (e)
-6.92 TWD
Jan 1, 2027 (e)
3.73 TWD
The Medeon Biodesign EBIT per Share history
YEAREBIT per ShareYoY
est3.73TWD-153.85%
est-6.92TWD-7.11%
-7.45TWD-21.27%
-9.47TWD+3.61%
-9.14TWD+64.12%
-5.57TWD-18.09%
-6.80TWD+409.70%
-1.33TWD-62.01%
-3.51TWD-225.59%
2.79TWD-164.34%
-4.34TWD+37.38%
-3.16TWD+13.93%
-2.78TWD+95.37%
-1.42TWD-64.66%
-4.02TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medeon Biodesign Stock analysis

What does Medeon Biodesign do? Medeon Biodesign Inc, headquartered in Taipei City, Taiwan, develops, manufactures, and sells medical equipment. Listed on 11 December 2014, the company specializes in medical apparatus and instruments for laparoscopic and cardiac catheter minimally invasive surgeries. Its products are distributed domestically and internationally, serving the Health Care sector with innovative surgical solutions. Medeon Biodesign is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medeon Biodesign stock

EBIT per Share of Medeon Biodesign is -7.45 TWD in 2025.

EBIT per Share of Medeon Biodesign changed from -9.47 TWD to -7.45 TWD, representing a -21.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Medeon Biodesign since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Medeon Biodesign

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Medeon Biodesign